Miclot joins Tengion

Tuesday, December 6, 2011 09:25 AM

Tengion has named John L. Miclot president and chief executive officer.

Most recently, Miclot was an executive-in-residence at Warburg Pincus. He also served as president and chief executive officer of CCS Medical.

"John's proven track record of driving company growth and realizing shareholder value make him an ideal choice to lead Tengion. As we continue to pursue strategic partnership and financing discussions, his experience will be invaluable and we look forward to working with him to achieve key Tengion milestones in 2012," said David I. Scheer, chairman of the board of directors of Tengion.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs